oxoguanine DNA glycosylase (Ogg1) repairs the 8-oxoguanine, one of the most abundant DNA adducts caused by oxygen free radicals. This study identified mitochondrial Ogg1 as a pathogenic mechanism in response to catabolic factors in osteoarthritis (OA). Methods: 8-oxoguanine and Ogg1 expressions were investigated in human OA cartilage and rat OA cartilage by immunohistologic analysis. We studied whether OA-related catabolic factors influence expression of Ogg1 or 8-oxoguanine in OA chondrocytes and analyzed the relationship among cellular function, apoptosis and Ogg1 or 8oxoguanine expression in human chondrocytes. Results: We observed the increased level of 8-oxoguanine and the decreased level of Ogg1 in OA chondrocytes in comparison with normal chondrocytes in OA rats as well as in patients with OA. OA-related catabolic factors induced the overexpression of 8-oxoguanine and down-regulation of Ogg1 in chondrocytes. We found that overexpression of mitochondria Ogg1 in OA chondrocytes prevents catabolic stress-induced mitochondrial dysfunction, caspase-9 activation and apoptosis in vitro. Furthermore, Ogg1 silencing using siRNA reduced chondrocyte activity and augments apoptosis in OA chondrocytes. Conclusions: The accumulation of an oxidized form of guanine, 8-oxoguanine, and down-regulation of its repair enzyme Ogg1 in OA chondrocytes may be involved in the pathogenesis of OA. Our study suggests that Ogg1 prevents catabolic stress-mediated chondrocyte dysfunction and apoptosis that might be associated with the maintenance of articular cartilage.
PHYSIOLOGICAL CONCENTRATIONS OF GLUCOSAMINE SULFATE AND GLUCOSAMINE HCL CAN DOWNREGULATE INTERLEUKIN-1, KININS AND MMPS IN HUMAN OSTEOARTHRITIC CHONDROCYTES
W. Wu, M. Pasierb. Henry Ford Hosp., Detroit, MI, USA Purpose: Glucosamine (GLN) products are taken by patients suffering from OA and other joint problems. In the United States it sold in the form of Glucosamine HCL (GHCl) as a nutritional supplement, while in Europe it is prescribed in the Glucosamine Sulfate (GS) form. In clinical trials both in the US and Europe has shown that GLN can reduce pain scores in patients with moderate to severe knee pain. Although GLN may be beneficial, their exact mechanism of action(s) remains obscure. Also because of the two different forms used, there is still controversy to which form of GLN is more effective. To further elucidate their mechanism of action, we determined the effects of both forms GLN at concentrations attainable in vivo and lower than those reported in in vitro studies, on selected pain mediators, inflammatory mediators, collagenases MMP-1 and MMP-13 using cytokine-stimulated human chondrocyte cultures. Methods: We took advantage of the recent pharmacokinetic information of GLN concentrations in plasma and synovial fluid to conduct our studies. Human (n¼3) OA chondrocytes (ages: 53, 59 & 62) were isolated from cartilage obtained from total knee arthroplasty. Chondrocytes were seeded at 0.5 X 10 6 cells/ml and cultured in the presence of DMEM plus 10% FBS for 48h. Pharmaceutical grade GS and GHCl were provided as kind gifts from Bioiberica, SA, Spain. The chondrocytes were then serum starved for 24h and treated with either of the following: Control (Ctrl), 5 ng/ml human recombinant IL-b (IL-1), 0.5mg/ml GS, 5.0mg/ml GS, 0.5mg/ml GHCl, 5.0mg/ ml GHCl, IL-1 + 0.5mg/ml GS, IL-1 + 5.0 mg/ml GS, IL-1 + 0.5mg/ml GHCl or IL-1 + 5.0 mg/ml GHCl. Cells and media were collected 48h after stimulation.
Total RNA was isolated from cells. Semi-quantative RT-PCR was uses to assess gene expression for Kininogen, IL-1b, IL-1b receptor, MMP-1 and MMP-13. Proteins of MMP-1 and MMP-13 secreted into the media were measured by Western blot. Gene and Western blot data were analyzed statistically using the student t-test. Different letters within a parameter indicate significant differences (P <0.05) differences between treatments.
Results: As expected, the addition of 5ng/ml of IL-1b stimulated the mRNA expression of IL-1b, IL-1 receptor, Kininogen, MMP-1 and MMP-13 in the OA chondrocytes. Chondrocytes cultured in the preseence of 0.5GS, 5.0 GS, 0.5 GHCl and 5.0 GHCl were all able to down-regulate the mRNA expression of these genes significantly. In most cases, both the GS and GHCl were able to repress expression to or below control levels. Purpose: Articular cartilage exhibits a limited ability to remove damaged tissue from its surfaces, a step integral for efficient mammalian wound healing that is typically enabled by polymorphonuclear neutrophil granulocytes in other tissue types. This limited ability constrains articular cartilage wound healing behaviors, contributing to lesion progression and the disease burden of osteoarthritis. The respiratory burst myeloperoxidase system of polymorphonuclear neutrophil granulocytes produces low stability protonating agents involved in exothermic tissue homeostasis and repair mechanisms through disproportionation redox reactions. Because these protonating agents facilitate the removal of damaged interstitial matrices through biopolymer disaggregation in order to assist differentiated tissue assembly activities, this study evaluates the capability of alternating current redox magnetohydrodynamic technology to mimic this respiratory burst to aid the wound healing behaviors of articular cartilage by creating a healthy lesion site devoid of damaged tissue.
Methods: An alternating current redox magnetohydrodynamic device fashioned as a physiochemical scalpel was deployed in 0.9% sodium chloride solutions at 300 mOsm/L and at 20 o C. Figure 1 demonstrates the device producing solution changes that are delivered to tissue surfaces as an engineered irrigant during endoscopic procedures designed to stabilize articular cartilage lesions.
ĂTo determine if the engineered irrigant resembles the protic solvent generated by azurophilic granules, the resultant irrigant temperature and protonation potential were measured as a function of power input during device activation controlled for 5 second steady-state treatment conditions. Irrigant protonation potential was determined by measuring solution electrochemical potential relative to [H + ] as a function of differential proton sequestration in the irrigant during device activation. Results: Alternating current redox magnetohydrodynamics in saline solutions is represented in Figure 2 .
ĂAs depicted in Figure 3 , the protonation potential increased with direct correlation to power delivery (p < 0.02; R 2 ¼ 0.311) and commensurate with a minimal change in irrigant temperature (w0-5 o C) above the baseline 20 o C, reflecting features characteristic of the protic solvent generated by the azurophilic degranulation of polymorphonuclear neutrophil granulocytes during the early phases of wound healing.
ĂConclusions: Because resection precision that eliminates both volumetric and functional over-resection is required before surgical lesion stabilization can be an effective aid to articular cartilage wound healing behaviors, polymorphonuclear neutrophil granulocyte function is a valuable therapeutic design resource. Protonation coupled conformational dynamics is an energy transduction processes that achieves nanometer resection precision through a guest chemical denaturization process below the isoelectric point of exposed damaged interstitial tissue matrices. Because of high proton motilities in water solutions, stoichiometric protonation is a very rapid charge redistribution process that leads to biopolymer disaggregation through molecular cleavage planes accessible due to normal tissue surface barrier losses and degenerate matrix properties characteristic of damage tissue sites. Figure 4 illustrates a representative integrated cell viability stain section image that demonstrates removing the bioburden of damaged tissue without iatrogenic over-resection in a human explant model of osteoarthritis by adapting alternating current redox magnetohydrodynamic technology for tissue rescue surgical procedures.
